Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

Keywords

Medicine, Human immunodeficiency virus (HIV), Antiretroviral therapy, ANTIRETROVIRAL AGENTS, Antiretroviral drug

References

• Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.H. Zylberberg, Jianhai Jiang, Gilles Pialoux — 1996
• Blood lactate: biochemistry, laboratory methods, and clinical interpretation.Sii Ling Mee Ling Mohammed Sani Bin Ibrahim — 1991
• Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitroAntonio Martínez Cutillas, Enrique Alarcón — 1997
• CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)Randi Schwartz — 1998
• Adolescents' perceptions of physicians, nurses, parents and friends: help or hindrance in compliance with diabetes self-care?严军 — 1998
• Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load.Ricardo D'Auria — 1999
• Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.Moshe Y. Vardi — 1999
• Hydroxyurea-induced hepatitis in human immunodeficiency virus-positive patients.眞人 川島, 直幸 伊東 — 1999
• Ritonavir and renal failure.S N Chugh, Ranjana P. Bird, E. A. Alexander — 1997
• Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.Israel Tonatiuh Lay Arellano — 2000
• Cervical Intraepithelial Neoplasia in Women Infected With Human Immunodeficiency Virus: Prevalence, Risk Factors, and Validity of Papanicolaou SmearsThomas C. Wright, Tedd V. Ellerbrock, Mary Ann Chiasson — 1994
• Drug abuse treatment as AIDS prevention.David S. Metzger, Helen Navaline, George Woody — 1998
• Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.David M. Simpson, Michele Tagliati — 1995
• HIV disease progrssion in injecting drug users: epidemiological studiesMaria Prins — 2000
• Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.Edward L. Schwartz, A B Brechbühl, P Kahl — 1992
• Introduction to the Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants.A. J. Ammann — 2000
• Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy.Fortgang Is, Belitsos Pc, Chaisson Re — 1995
• Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.Diana Hartel, Ellie E. Schoenbaum — 1998
• Hydroxyurea as a reference standard in teratological screening. Comparison of the embryotoxic and teratogenic effects following single intraperitoneal or repeated oral administrations to pregnant rats.Aliverti, L Bonanomi, E. Giavini — 1980
• Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Vol. 47/No. RR-5.Mark B. Feinberg, Jonathan E. Kaplan — 1998

Cited by

• VIH : comment la recherche en épidémiologie s’est orientée de l’évaluation thérapeutique au dépistage et à la préventionKaren Champenois — 2011
• Diagnosis of Acute HIV Infection in ConnecticutRobert Dubrow, Kathleen J. Sikkema, Kenneth H. Mayer — 2009
• Response of Lymphoepithelial Parotid Cysts to Antiretroviral Treatment in HIV-Infected Adults達也 小室 — 1998
• Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.典仁 岩渕 — 2000
• Pharmacologic management of HIV/STD exposure.s.kom. mohammad mahendra jaya wardana — 2000
• HIV Antiretroviral Treatment: Early Versus LaterJosephine Mauskopf, Mari M. Kitahata, Teresa L. Kauf — 2005
• Hepatitis C virus and human immunodeficiency virus coinfection in Spain.Dan Kaminski — 2003
• Antiretroviral-associated liver injury.Rafael G. Sola, Paloma Pulido, Jesús Pastor — 2003
• The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.三浦 雅彦, Lori K E Rodrigues, Niloufar Ameli — 2004
• Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.Daniel P. Bunting — 2004
• Pharmacokinetics of Indinavir at 800, 600, and 400 Milligrams Administered with Ritonavir at 100 Milligrams and Efavirenz in Ethnic Chinese Patients Infected with Human Immunodeficiency VirusAna Delia Brito — 2004
• Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven.Ted D. Blacker — 2005
• Atherosclerotic Cardiovascular Disease Risk in the HAART-Treated HIV-1 PopulationM. F. El-Shahat Nehal, Muredach P. Reilly — 2005
• Physician specialization and the quality of care for human immunodeficiency virus infection.彰 大島, 博臣 河野, 千春 久保 — 2005
• Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.I Gusti Ngurah Surya Winata — 2005
• Nonoccupational HIV postexposure prophylaxis.Juan‐Ying Li, Jennifer Bräunig, Ling Jin — 2005
• Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus–Coinfected Subjects With Hepatic ImpairmentJavier Plaza Penadés — 2006
• Patterns of HIV Care for Patients with Serious Mental IllnessYamile León Vargas — 2006
• Changing antiretroviral therapy in the setting of virologic relapse: Review of the current literatureSalvador del Rey Guanter — 2006
• AIDS Policy Modeling for the 21st Century: An Overview of Key IssuesMarion S. Rauner, Margaret L. Brandeau — 2001

Related papers

• The Sexual Behaviours of HIV Positive Patients Receiving Antiretroviral Therapy in HIV Treatment Centre in NigeriaAgu Kenneth Igbe Ighodaro — 2014
• Antiretroviral Therapy for the Treatment of HIVStella Mcguire — 2021
• The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment What Do We Really Know?Mary Glenn Fowler, Lynne Mofenson, Michelle S. McConnell — 2003
• Emerging trends in antiretroviral therapy and drug resistance: A perspective on treatment of HIVSanjita Das — 2013
• New horizons: antiretroviral therapy in 1997.Ann B. Williams — 1997
• Improving adherence to antiretroviral therapy.Eric S. Daar, Calvin Cohen, Robert H. Remien — 2003
• Antiretroviral therapy: treatment-experienced individuals.Katya R. Calvo, Eric S. Daar — 2014